UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

Pegloticase efficacy and safety in kidney transplant recipients; results of the phase IV, open-label PROTECT clinical trial

Clinical transplantation, 2023-09, Vol.37 (9), p.e14993-e14993

2023

Volltextzugriff (PDF)

Projected Health and Economic Burden of Comorbid Gout and Chronic Kidney Disease in a Virtual US Population: A Microsimulation Study

Rheumatology and therapy., 2024-08, Vol.11 (4), p.913-926

2024

Volltextzugriff (PDF)

Gout among Patients with Dialysis: Prevalence, Associated Factors, Treatment Patterns, and Outcomes-Population-Based Retrospective Cohort Study

Kidney360, 2023-02, Vol.4 (2), p.177

2023

Volltextzugriff (PDF)

Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients

Transplantation direct, 2016-04, Vol.2 (4), p.e69-e69

2016

Volltextzugriff (PDF)

A monocyte chemoattractant protein-1 (MCP-1) polymorphism and outcome after renal transplantation

Journal of the American Society of Nephrology, 2002-10, Vol.13 (10), p.2585-2589

2002

Volltextzugriff (PDF)

Intensive urate-lowering with pegloticase plus methotrexate co-therapy in uncontrolled gout patients with and without chronic kidney disease: A retrospective case series

Medicine (Baltimore), 2024-03, Vol.103 (10), p.e37424-e37424

2024

Volltextzugriff (PDF)

eGFR Changes in Uncontrolled Gout Patients Undergoing Pegloticase Plus Methotrexate Co-Therapy: SA-PO897

Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.851-851

2022

Volltextzugriff (PDF)

eGFR Changes in Uncontrolled Gout Patients Randomized to Receive Methotrexate or Placebo as Co-Therapy to Pegloticase: MIRROR RCT Findings: SA-PO898

Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.851-851

2022

Volltextzugriff (PDF)

DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS

Journal of the American Society of Nephrology, 2018-11, Vol.29 (11), p.2745-2754

2018

Volltextzugriff (PDF)

Claims-Based Evaluation of Pegloticase Use in Gout Patients with a History of Kidney Transplant: PUB317

Journal of the American Society of Nephrology, 2021-10, Vol.32 (10S), p.853-853

2021

Volltextzugriff (PDF)

Risk Factors and Outcomes of Gout in Dialysis Patients: A Cohort Study of the United States Renal Data System (USRDS): PO0792

Journal of the American Society of Nephrology, 2021-10, Vol.32 (10S), p.277-277

2021

Volltextzugriff (PDF)

The Impact of Costimulatory Molecule Gene Polymorphisms on Clinical Outcomes in Liver Transplantation

American journal of transplantation, 2003-04, Vol.3 (4), p.424-431

2003

Volltextzugriff (PDF)

Hyperuricemia in Patients With Advanced CKD: Potential Impacts of This Often Overlooked Issue: PUB355

Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.983-983

2022

Volltextzugriff (PDF)

Pharmacokinetics and Immunogenicity of Pegloticase in Patients With Kidney Transplants Receiving Pegloticase for Uncontrolled Gout: FR-PO232

Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.390-390

2022

Volltextzugriff (PDF)

A USRDS Database Study on the Use of Pegloticase in Patients Undergoing Dialysis: PO1166

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.391-392

2020

Volltextzugriff (PDF)

Characterization of Gout in US Patients Treated with Hemodialysis (HD) and Peritoneal Dialysis (PD): PO0800

Journal of the American Society of Nephrology, 2021-10, Vol.32 (10S), p.279-279

2021

Volltextzugriff (PDF)

Gout in Advanced CKD Patients: Prevalence and Impact on Patient Health: PUB316

Journal of the American Society of Nephrology, 2021-10, Vol.32 (10S), p.853-853

2021

Volltextzugriff (PDF)

Pegloticase for Uncontrolled Gout in Kidney Transplant Recipients: Provisional Data Report of a Multicenter, Open-Label, Efficacy and Safety Study: PO2117

Journal of the American Society of Nephrology, 2021-10, Vol.32 (10S), p.647-648

2021

Volltextzugriff (PDF)

Pegloticase for Uncontrolled Gout in Kidney Transplant Recipients: Early Data Report of a Multicenter, Open-Label Efficacy and Safety Study: PO2481

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.753-753

2020

Volltextzugriff (PDF)

Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features

Archives of neurology (Chicago), 2004-08, Vol.61 (8), p.1210

2004

Volltextzugriff (PDF)

Gout Prevalence, Practice Patterns, and Associations with Outcomes in North American Dialysis Patients

Kidney360, 2023-01, Vol.4 (1), p.54

2023

Volltextzugriff (PDF)

Telomere dynamics in an immortal human cell line

The EMBO journal, 1994-10, Vol.13 (20), p.4953-4962

1994

Volltextzugriff (PDF)

Delayed chromosomal instability induced by DNA damage

Molecular and Cellular Biology, 1993-11, Vol.13 (11), p.6667-6677

1993

Volltextzugriff (PDF)

Genetic variability and transplantation

Current opinion in urology, 2003-03, Vol.13 (2), p.81-89

2003

Volltextzugriff (PDF)

The Impact of Polymorphisms in Chemokine and Chemokine Receptors on Outcomes in Liver Transplantation

American journal of transplantation, 2002-08, Vol.2 (7), p.640-645

2002

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

Pegloticase efficacy and safety in kidney transplant recipients; results of the phase IV, open-label PROTECT clinical trial

Projected Health and Economic Burden of Comorbid Gout and Chronic Kidney Disease in a Virtual US Population: A Microsimulation Study

Gout among Patients with Dialysis: Prevalence, Associated Factors, Treatment Patterns, and Outcomes-Population-Based Retrospective Cohort Study

Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients

A monocyte chemoattractant protein-1 (MCP-1) polymorphism and outcome after renal transplantation

Intensive urate-lowering with pegloticase plus methotrexate co-therapy in uncontrolled gout patients with and without chronic kidney disease: A retrospective case series

eGFR Changes in Uncontrolled Gout Patients Undergoing Pegloticase Plus Methotrexate Co-Therapy: SA-PO897

eGFR Changes in Uncontrolled Gout Patients Randomized to Receive Methotrexate or Placebo as Co-Therapy to Pegloticase: MIRROR RCT Findings: SA-PO898

DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS

Claims-Based Evaluation of Pegloticase Use in Gout Patients with a History of Kidney Transplant: PUB317

Risk Factors and Outcomes of Gout in Dialysis Patients: A Cohort Study of the United States Renal Data System (USRDS): PO0792

The Impact of Costimulatory Molecule Gene Polymorphisms on Clinical Outcomes in Liver Transplantation

Hyperuricemia in Patients With Advanced CKD: Potential Impacts of This Often Overlooked Issue: PUB355

Pharmacokinetics and Immunogenicity of Pegloticase in Patients With Kidney Transplants Receiving Pegloticase for Uncontrolled Gout: FR-PO232

A USRDS Database Study on the Use of Pegloticase in Patients Undergoing Dialysis: PO1166

Characterization of Gout in US Patients Treated with Hemodialysis (HD) and Peritoneal Dialysis (PD): PO0800

Gout in Advanced CKD Patients: Prevalence and Impact on Patient Health: PUB316

Pegloticase for Uncontrolled Gout in Kidney Transplant Recipients: Provisional Data Report of a Multicenter, Open-Label, Efficacy and Safety Study: PO2117

Pegloticase for Uncontrolled Gout in Kidney Transplant Recipients: Early Data Report of a Multicenter, Open-Label Efficacy and Safety Study: PO2481

Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features

Gout Prevalence, Practice Patterns, and Associations with Outcomes in North American Dialysis Patients

Telomere dynamics in an immortal human cell line

Delayed chromosomal instability induced by DNA damage

Genetic variability and transplantation

The Impact of Polymorphisms in Chemokine and Chemokine Receptors on Outcomes in Liver Transplantation

Suchergebnisse filtern